Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
US cancer death rate has declined for at least 25 years
Fred Hutch experts weigh in on milestone report from American Cancer Society
Dr. Joachim Deeg named Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair for Cancer Research
Endowment will support future research for myelodysplastic syndromes
Rolling up the miles for cancer research
Obliteride riders, walkers top $2 million in Fred Hutch fundraiser
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Overcoming androgen therapy resistance in prostate cancer
From the Peter Nelson Lab, Human Biology Division
'Movember' a reminder for dudes to go to the doctor
Growing facial hair in November part of spotlight on men’s health awareness — and the lack thereof
Targeted therapies push metastatic prostate cancer in new directions
Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments
Removing barriers to precision treatment of metastatic prostate cancer
GENTleMEN study aims to help men with advanced disease access genetic testing and counseling
Good News: NCI awards Dr. Ruth Etzioni 5-year grant to fill gaps in cancer-recurrence data
Celebrating faculty and staff achievements
The path to precision screening for cancer
For now, early detection of breast and prostate cancer means mammograms and PSAs, but a more tailored approach is on the horizon
Good News: Dr. Cyrus Ghajar receives $1M from Keck Foundation to study why cancer doesn’t spread to skeletal muscle
Celebrating faculty and staff achievements
Prostate cancer researcher cycles to save lives
Five-year Obliteride veteran Dr. Pete Nelson rides to make inroads against all cancers
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
Beyond Ben Stiller’s advice: What the experts say about PSA screening
The actor said a ‘prostate cancer test saved my life’; experts weigh in on when (and if) men should be screened
Seattle Mariners GM Jerry Dipoto, broadcaster Dave Sims tour Fred Hutch
‘You learn to be resilient’: In baseball, both men found lessons to help overcome cancer diagnoses and treatment
Testing for inherited mutations could benefit men with advanced prostate cancer
Familial errors in DNA-repair genes are unexpectedly common in men with metastatic prostate cancer, and could help guide therapy and inform cancer screening in family members
Inherited mutations tied to advanced prostate cancer
Genetic screening could help men with prostate cancer find better treatments — and alert family members to their own cancer risk
Is metastatic prostate cancer tailor-made for precision oncology?
New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients
Good News at Fred Hutch
<p>Dr. Peter Nelson to lead $1M study of metastatic prostate cancer; more than two dozen Hutch researchers to present at largest statistical conference in North America</p>
Good News at Fred Hutch
Dr. Peter Nelson principal researcher on prostate cancer 'Dream Team'; Dr. Kathi Malone honored by Komen Puget Sound; Dr. Eric Chow leads study of cardioprotective drug that addresses chemo concerns in children; and Dr. Linda Buck receives honorary doctorate from Harvard
Movember-PCF challenge award
Study leader and ‘Mo Bro’ Pete Nelson sprouts moustache to raise awareness of prostate cancer